{"id":830442,"date":"2025-03-27T07:09:25","date_gmt":"2025-03-27T11:09:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/"},"modified":"2025-03-27T07:09:25","modified_gmt":"2025-03-27T11:09:25","slug":"beyondspring-files-2024-annual-report-on-form-10-k","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/","title":{"rendered":"BeyondSpring Files 2024 Annual Report on Form 10-K"},"content":{"rendered":"
\n

FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc.<\/strong><\/a> (NASDAQ: BYSI) (\u201cBeyondSpring\u201d or the \u201cCompany\u201d), a global clinical-stage biopharmaceutical company developing innovative cancer therapies, today announced that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on March 27, 2025. The annual report on Form 10-K, which contains the Company\u2019s audited consolidated financial statements, can be accessed on the SEC\u2019s website at www.sec.gov<\/a> and on the Company\u2019s website at www.beyondspringpharma.com<\/a> under \u201cFinancials & Filings\u201d in the Investors section.<\/p>\n

The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to Investor Relations, BeyondSpring Inc., 100 Campus Drive, Suite 410, Florham Park, NJ 07932 USA.<\/p>\n

\n About BeyondSpring<\/strong>
\n
\n BeyondSpring<\/a> (NASDAQ: BYSI) is a\u00a0clinical-stage biopharmaceutical company<\/strong>\u00a0developing\u00a0first-in-class therapies<\/strong> for high unmet medical needs. Its lead asset,\u00a0Plinabulin<\/strong>, is in\u00a0late-stage clinical development<\/strong>\u00a0as an anti-cancer agent in NSCLC and a range of cancer indications. Plinabulin\u2019s novel mechanism of action as a\u00a0dendritic cell maturation agent<\/strong>\u00a0supports both\u00a0anti-cancer activity and immune modulation<\/strong>, offering a unique approach to\u00a0resensitizing tumors to checkpoint inhibitors<\/strong>. Learn more at\u00a0beyondspringpharma.com<\/a>.<\/p>\n

\n Cautionary Note Regarding Forward-Looking Statements<\/strong>
\n
This press release includes forward-looking statements that are not historical facts. Words such as \u201cwill,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cdesign,\u201d \u201cmay,\u201d \u201cfuture,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cobjective,\u201d \u201cgoal,\u201d or variations thereof and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are based on BeyondSpring\u2019s current knowledge and its present beliefs and expectations regarding possible future events and are subject to risks, uncertainties, and assumptions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors including, but not limited to, difficulties raising the anticipated amount needed to finance the Company\u2019s future operations on terms acceptable to the Company, if at all, unexpected results of clinical trials, delays or denial in regulatory approval process, results that do not meet the Company\u2019s expectations regarding the potential safety, the ultimate efficacy or clinical utility of the Company\u2019s product candidates, increased competition in the market, the Company\u2019s ability to meet Nasdaq\u2019s continued listing requirements, and other risks described in BeyondSpring\u2019s most recent Form 10-K on file with the U.S. Securities and Exchange Commission. All forward-looking statements made herein speak only as of the date of this release and BeyondSpring undertakes no obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as otherwise required by law.<\/p>\n

\n Investor Contact: <\/strong>
\n IR@beyondspringpharma.com<\/a>
\n
\n Media Contact: <\/strong>
\n PR@beyondspringpharma.com<\/a>\n <\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (\u201cBeyondSpring\u201d or the \u201cCompany\u201d), a global clinical-stage biopharmaceutical company developing innovative cancer therapies, today announced that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on March 27, 2025. The annual report on Form 10-K, which contains the Company\u2019s audited consolidated financial statements, can be accessed on the SEC\u2019s website at www.sec.gov and on the Company\u2019s website at www.beyondspringpharma.com under \u201cFinancials & Filings\u201d in the Investors section. The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon … <\/p>\n

Continue reading “BeyondSpring Files 2024 Annual Report on Form 10-K”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-830442","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (\u201cBeyondSpring\u201d or the \u201cCompany\u201d), a global clinical-stage biopharmaceutical company developing innovative cancer therapies, today announced that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on March 27, 2025. The annual report on Form 10-K, which contains the Company\u2019s audited consolidated financial statements, can be accessed on the SEC\u2019s website at www.sec.gov and on the Company\u2019s website at www.beyondspringpharma.com under \u201cFinancials & Filings\u201d in the Investors section. The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon … Continue reading "BeyondSpring Files 2024 Annual Report on Form 10-K"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T11:09:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BeyondSpring Files 2024 Annual Report on Form 10-K\",\"datePublished\":\"2025-03-27T11:09:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/\"},\"wordCount\":467,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/\",\"name\":\"BeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=\",\"datePublished\":\"2025-03-27T11:09:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beyondspring-files-2024-annual-report-on-form-10-k\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeyondSpring Files 2024 Annual Report on Form 10-K\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/","og_locale":"en_US","og_type":"article","og_title":"BeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk","og_description":"FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (\u201cBeyondSpring\u201d or the \u201cCompany\u201d), a global clinical-stage biopharmaceutical company developing innovative cancer therapies, today announced that it has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on March 27, 2025. The annual report on Form 10-K, which contains the Company\u2019s audited consolidated financial statements, can be accessed on the SEC\u2019s website at www.sec.gov and on the Company\u2019s website at www.beyondspringpharma.com under \u201cFinancials & Filings\u201d in the Investors section. The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon … Continue reading \"BeyondSpring Files 2024 Annual Report on Form 10-K\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-27T11:09:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BeyondSpring Files 2024 Annual Report on Form 10-K","datePublished":"2025-03-27T11:09:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/"},"wordCount":467,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/","name":"BeyondSpring Files 2024 Annual Report on Form 10-K - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=","datePublished":"2025-03-27T11:09:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMTg4MSM2ODM3MTMwIzIwODA4ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beyondspring-files-2024-annual-report-on-form-10-k\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BeyondSpring Files 2024 Annual Report on Form 10-K"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=830442"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830442\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=830442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=830442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=830442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}